Advanced Lung Cancer Treatment With Metformin and Chemo-Radiotherapy (ALMERA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02115464

Recruitment Status : Terminated (The accrual rate was not high enough to reach the target sample size.)

First Posted : April 16, 2014

Last Update Posted : April 22, 2020

Sponsor:

Collaborator:

Canadian Institutes of Health Research (CIHR)

Information provided by (Responsible Party):

Ontario Clinical Oncology Group (OCOG)

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Terminated
Actual Primary Completion Date :	March 9, 2020
Actual Study Completion Date :	April 21, 2020

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Tsakiridis T, Pond GR, Wright J, Ellis PM, Ahmed N, Abdulkarim B, Roa W, Robinson A, Swaminath A, Okawara G, Wierzbicki M, Valdes M, Levine M. Metformin in Combination With Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer: The OCOG-ALMERA Randomized Clinical Trial. JAMA Oncol. 2021 Sep 1;7(9):1333-1341. doi: 10.1001/jamaoncol.2021.2328.

To Top